Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Susan L, Benedict"'
Autor:
M. Elizabeth Brickner, Reed E. Pyeritz, Kathryn C. Chatfield, Dianna M. Milewicz, Anthony L. Estrera, Ellen S. Regalado, Hiroko Morisaki, Patricia L. Musolino, Lauren Mellor-Crummey, Susan L. Benedict, Mustafa Tekin, Denver Sallee, Kathryn W. Holmes, Timothy J. Bradley, Cori Feist, Glen J. Iannucci, Julie Richer, Sherene Shalhub, John R. Østergaard, Lesley C. Adès, Anne H. Child, Paul R. Mark, Shaine A. Morris, Anna L. Mitchell, Birgit Lorenz, Julie De Backer, Takayuki Morisaki, Anji T. Yetman, Alan C. Braverman
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics
Regalado, E S, Mellor-Crummey, L, De Backer, J, Braverman, A C, Ades, L, Benedict, S, Bradley, T J, Brickner, M E, Chatfield, K C, Child, A, Feist, C, Holmes, K W, Iannucci, G, Lorenz, B, Mark, P, Morisaki, T, Morisaki, H, Morris, S A, Mitchell, A L, Ostergaard, J R, Richer, J, Sallee, D, Shalhub, S, Tekin, M, Estrera, A, Musolino, P, Yetman, A, Pyeritz, R, Milewicz, D M & Montalcino Aortic Consortium 2018, ' Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations ', Genetics in Medicine, vol. 20, no. 10, pp. 1206-1215 . https://doi.org/10.1038/gim.2017.245
Regalado, E S, Mellor-Crummey, L, De Backer, J, Braverman, A C, Ades, L, Benedict, S, Bradley, T J, Brickner, M E, Chatfield, K C, Child, A, Feist, C, Holmes, K W, Iannucci, G, Lorenz, B, Mark, P, Morisaki, T, Morisaki, H, Morris, S A, Mitchell, A L, Ostergaard, J R, Richer, J, Sallee, D, Shalhub, S, Tekin, M, Estrera, A, Musolino, P, Yetman, A, Pyeritz, R, Milewicz, D M & Montalcino Aortic Consortium 2018, ' Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations ', Genetics in Medicine, vol. 20, no. 10, pp. 1206-1215 . https://doi.org/10.1038/gim.2017.245
Purpose: Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complication
Autor:
Warren D. Lo, Susan L. Benedict, Carlos Leiva-Salinas, Nomazulu Dlamini, Abdalla Ali Abdalla, Sally Sultan, Rebecca Ichord, L.P. Zou, Mark T Mackay, Jerome Y. Yager, Neil R. Friedman, J. Condie, Michael J. Rivkin, Katherine Sear, Timothy J. Bernard, Anthony K.C. Chan, Nancy K. Hills, Lori C. Jordan, Guangming Zhu, Gabrielle deVeber, Osman Farooq, Qinghua Hou, Jessica L. Carpenter, Luigi Titomanlio, Paola Pergami, Bruce Bjornson, Max Wintermark, Michael M. Dowling, Virginia Wong, Ming K. Lim, Gordana Kovacevic, R. Kneen, Adam Kirton, Christine K. Fox, Peter Humphreys, A. James Barkovich, Jorina Elbers, Catherine Amlie-Lefond, Rob Forsyth, Mubeen F. Rafay, Mitchell S.V. Elkind, A. Yeh, M. Hernández Chávez, Marilyn Tan, Steven G. Pavlakis, Heather J. Fullerton
Publikováno v:
Stroke. 45:3597-3605
Background and Purpose— Although arteriopathies are the most common cause of childhood arterial ischemic stroke, and the strongest predictor of recurrent stroke, they are difficult to diagnose. We studied the role of clinical data and follow-up ima
Autor:
Heather J. Fullerton, Rebecca Ichord, Abbas F. Jawad, Susan L. Benedict, Scott E. Kasner, Warren D. Lo, Marilyn Tan, Rachel A Bastian, Daniel J. Licht, Timothy J. Bernard, Li Kan, Catherine Amlie-Lefond, Lauren A. Beslow, Michael M. Dowling, Neil R. Friedman, Adam Kirton, Steve Pavlakis, Sabrina E. Smith, Gabrielle deVeber, Lori C. Jordan, Lisa Abraham, Rand Askalan, Chalmer McClure
Publikováno v:
Stroke. 42:613-617
Background and Purpose— Stroke is an important cause of death and disability among children. Clinical trials for childhood stroke require a valid and reliable acute clinical stroke scale. We evaluated interrater reliability (IRR) of a pediatric ada
Publikováno v:
Archives of disease in childhood. 100(2)
Objectives We evaluated clinical features, treatment practices and early outcome in a multicentre cohort of children with cerebral sinovenous thrombosis (CSVT). Methods Children with CSVT from 10 countries were enrolled from January 2003 to July 2007
Autor:
Rebecca Ichord, Catherine Amlie-Lefond, Adam Kirton, Collin A. Hovinga, Gabrielle de Veber, Jorina Elbers, Anthony K.C. Chan, Marcela Torres, Joan Cox Gill, Hugh J. McMillan, Dana D Cummings, James C. Grotta, Susan L. Benedict, Lori C. Jordan, Lauren A. Beslow, Neil R. Friedman, Michael M. Dowling, Michael J. Rivkin, Sally Sultan, Kelley Scholz, Timothy J. Bernard, Eric F. Grabowski
Publikováno v:
Stroke. 45(7)
Background and Purpose— In adult stroke, the advent of thrombolytic therapy led to the development of primary stroke centers capable to diagnose and treat patients with acute stroke rapidly. We describe the development of primary pediatric stroke c
Publikováno v:
Journal of Child Neurology. 22:225-227
Recombinant tissue plasminogen activator, although the standard of care for the management of acute ischemic stroke in adults, is used infrequently in children. The authors describe the use of intra-arterial recombinant tissue plasminogen activator i
Autor:
Rebecca N Ichord, Rachel A Bastian, Lisa Abraham, Susan L Benedict, Timothy J Bernard, Lauren A Beslow, Gabrielle de Veber, Michael Dowling, Neil R Friedman, Heather J Fullerton, Lori C Jordan, Li Kan, Scott E Kasner, Adam Kirton, Catherine Amlie-Lefond, Daniel J Licht, Warren Lo, Chalmer McClure, Steve Pavlakis, Sabrina E Smith, Abbas F Jawad
Publikováno v:
Stroke. 43
Background: Stroke is an important cause of death and disability among children. Clinical trials for childhood stroke will require a valid acute clinical stroke scale. We evaluated predictive validity of a pediatric adaptation of the NIH Stroke Scale
Autor:
James L, Hoffman, Gordon K, Mack, L LuAnn, Minich, Susan L, Benedict, Mason, Heywood, Gregory J, Stoddard, Elizabeth V, Saarel
Publikováno v:
Congenital heart disease. 6(3)
Over the past three decades, significant advances in treatment have improved the mortality of children with cardiac disease. The effect of these advances on the prevalence of arterial ischemic stroke (AIS) is unknown. We describe AIS in children with
Autor:
Mark T, Mackay, Max, Wiznitzer, Susan L, Benedict, Katherine J, Lee, Gabrielle A, Deveber, Vijeya, Ganesan, Andrew, Willan
Publikováno v:
Annals of neurology. 69(1)
Objective To describe presumptive risk factors (RFs) for childhood arterial ischemic stroke (AIS) and explore their relationship with presentation, age, geography, and infarct characteristics. Methods Children (29 days–18 years) were prospectively
Publikováno v:
Pediatric neurology. 41(4)
Genotyping for the methylenetetrahydrofolate reductase gene ( MTHFR ) has been recommended for part of the evaluation for underlying prothrombotic state in childhood stroke; however, studies are inconclusive regarding the role of this gene and also t